Eisai Company Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Eisai Company Limited with three other
companies in this sector in Japan:
Mitsubishi Tanabe Pharma Corp
sales of 431.70 billion Japanese Yen [US$3.86 billion]
of which 100%
was Pharmaceutical Products),
Chugai Pharmaceutical Co Ltd
(491.78 billion Japanese Yen [US$4.40 billion]
Kyowa Hakko Kirin Company Limited
(343.02 billion Japanese Yen [US$3.07 billion]
of which 77%
was Pharmaceutical Business).
Eisai Company Limited reported sales of ¥547.92 billion (US$4.90 billion)
March of 2016.
decrease of 0.1%
versus 2015, when the company's sales were ¥548.47 billion.